SpeechATAXIA- a multinational, multilanguage consortia for speech in hereditary ataxias – powered by Redenlab

Redenlab is supporting a new speech focussed consortium for ataxia. SpeechATAXIA is a multi-language, multi-national, multi-ataxia study measuring communication change. Participants are recruited from investigator sites in Australia, New Zealand, Europe, North and South America.

The consortia goals include:
Precisely describe longitudinal changes occurring in speech as disease progresses,
– Identify predictors of progression and discover if critical milestones exist in the disease course,
– Explore how communication decline shapes quality of life and disease management,
– Strengthen genotype-phenotype associations to create disease specific profiles.

The program of research is supported by the Ataxia Global Initiative.

Related Post

  • Posted on 25 July, 2025
    A new clinical trial has found early evidence that a metabolic therapy could improve outcomes for people with ataxia-telangiectasia (A-T),...
    • Posted on 26 June, 2025
      Pain is deeply personal, yet universally expressed through speech. But what if speech isn’t just a way we describe pain,...
      • Posted on 17 June, 2025
        A new study published in the European Journal of Human Genetics provides the first systematic analysis of speech and language...